Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Heartflow (Nasdaq: HTFL) will report fourth quarter and full year 2025 financial results after market close on March 18, 2026.

Rhea-AI Summary

Heartflow (Nasdaq: HTFL) will report fourth quarter and full year 2025 financial results after market close on March 18, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET the same day with a live webcast and archived replay available for 12 months.

Investors must register to receive dial-in numbers and a unique PIN; participants are encouraged to register at least 15 minutes before the call.

Argus Feb 17 session

+7.79% close to close Open Argus

Details

News Market Reaction – HTFL

In the Feb 17 session, HTFL gained 7.79%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +7.8% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +7.8% in the session following this news. A strong positive reaction aligns with the pattern seen after earlier clinical and reimbursement milestones, where news on payer coverage, guideline support, or large real‑world datasets previously coincided with gains of up to 6.49%. Investors would still need to weigh recent insider Form 4 sales and multiple Form 144 filings when assessing how durable such a move might be into and after the March 18, 2026 earnings release.

Key Figures

Earnings release date: March 18, 2026 Conference call time PT: 1:30 p.m. PT Conference call time ET: 4:30 p.m. ET +1 more

Earnings release date

March 18, 2026

Q4 and full-year 2025 results after market close

Conference call time PT

1:30 p.m. PT

Start time for results call on March 18, 2026

Conference call time ET

4:30 p.m. ET

Start time for results call on March 18, 2026

Webcast archive length

12 months

Duration archived call will remain available on Investor Relations site

Historical Context

5 past events · Latest: Feb 12

5 events

1. Feb 12

   Registry expansion

   24h Move

   -16.6%

   Expanded GAMEFILM Registry to include former NBA and NHL players.

2. Jan 06

   Coverage expansion

   24h Move

   +2.5%

   Aetna added nationwide coverage for Heartflow Plaque Analysis across key plans.

3. Jan 05

   Conference participation

   24h Move

   +2.5%

   Management presented at the 44th J.P. Morgan Healthcare Conference.

4. Dec 18

   Guideline endorsement

   24h Move

   +6.5%

   ACC/AHA statements highlighted Heartflow-based pathways for CAD management.

5. Dec 11

   Outcomes and economics

   24h Move

   +1.0%

   Real‑world analyses in >90,000 patients showed prognostic power and cost savings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MOUNTAIN VIEW, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Wednesday, March 18, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on March 18, 2026.

Those interested in listening to the conference call should register online using this link. Once registered, participants will receive dial-in numbers and a unique PIN to join the call. Participants are encouraged to register more than 15 minutes prior to the start of the call. A live and archived webcast of the event will also be available on the “Investor Relations” section of the Heartflow website at https://ir.heartflow.com. The archived version will be available for 12 months following completion of the live call.

About Heartflow’s Technology and Research
Heartflow’s technology is redefining precision cardiovascular care through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,400 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by ACC/AHA guidelines and supported by more than 600 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 500,000 patients worldwide.¹ Key benefits include:

• Proprietary data pipeline: Built from more than 160 million annotated CTA images, Heartflow’s data foundation powers advanced AI models that deliver highly accurate, reproducible insights across diverse patient populations.
• Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 200 studies assessing over 365,000 patients. Proven in real-world practice with reproducibility and accuracy, Heartflow’s coronary CTA image acceptance rates exceed 97%.
• Seamless clinical integration via upgraded workflow: Heartflow delivers final quality-reviewed analyses instantly upon order, enabling clinicians to move from diagnosis to decision without delay.
• Quality system, global security and patient-data integrity compliance: Heartflow meets or exceeds leading international standards, including HITRUST, SOC 2 Type 2, ISO 13485, and ISO 27001.
  
  

About Heartflow, Inc.
Heartflow is transforming coronary artery disease from the world’s leading cause of death into a condition that can be detected early, diagnosed accurately, and managed for life. The Heartflow One platform uses AI to turn coronary CTA images into personalized 3D models of the heart, providing clinically meaningful, actionable insights into plaque location, volume, and composition and its effect on blood flow — all without invasive procedures. Discover how we’re shaping the future of cardiovascular care at heartflow.com.

Investor Contact
Nick Laudico
nlaudico@heartflow.com

Media Contact
Elliot Levy
elevy@heartflow.com

____________________
¹Gulati, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation & Diagnosis of Chest Pain. J Am Coll Cardiol.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Heartflow (HTFL) report Q4 and full year 2025 results?

Heartflow will release fourth quarter and full year 2025 results after market close on March 18, 2026. According to Heartflow, management will discuss results on a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET.

What time is the Heartflow (HTFL) earnings conference call on March 18, 2026?

The Heartflow earnings call begins at 1:30 p.m. PT / 4:30 p.m. ET on March 18, 2026. According to Heartflow, registrants will receive dial-in numbers and a unique PIN to join the live call and webcast.

How can investors join the Heartflow (HTFL) March 18, 2026 webcast and replay?

Investors can join via a live webcast and access an archived replay on the Heartflow investor website. According to Heartflow, the archived webcast will be available for 12 months after the live call.

Do I need to register to join the Heartflow (HTFL) March 18 earnings call?

Yes, registration is required to receive dial-in numbers and a unique PIN for the Heartflow earnings call. According to Heartflow, participants are encouraged to register more than 15 minutes before the start of the call.

Where will Heartflow (HTFL) post the earnings webcast and investor materials?

Heartflow will post the live webcast and archived materials in the Investor Relations section of its website. According to Heartflow, the webcast link and replay will be available at https://ir.heartflow.com for one year.